Products Category
Pharmaceutical Intermediate
Anti-VirusContact Us
Name: Ada Miao
Tel: +86-21-57856308
Mobile: +86-15800805830
E-mail: miao@lewoopharma.com; miaoshuangyu@vip.163.com
Add: Yank Plaza, No.1111, Xinzhen Street, Songjiang District, Shanghai City,China.
WeChat: 15800805830
whatsapp: 15800805830
QQ:
874857614
|
Product name : Empagliflozin
Product No. : 864070-44-0
|
| Details: |
Epagliflozin, a sodium dependent glucose cotransporter chemical Book 2 (sglt-2) inhibitor, was developed by Boehringer Ingelheim company and Lilly company. Sglt-2 inhibitor is a new type of hypoglycemic drug. It can reduce the reabsorption of glucose by kidney and increase the excretion of glucose in urine by inhibiting the expression of sglt-2. Its hypoglycemic effect is independent of β - cell function and insulin resistance.
|
| Related Products : |
|
|
|
|
||||||||
|
|
|
|
Chinese
Deutsch
Espanol
Francais
Italiano
Portugues
Japanese
Korean
Arabic
Russian
